PEAK6’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$44.6K Hold
1,000
– – ﹤0.01% 2356
2026
Q2
$79.3K Hold
1,000
– – ﹤0.01% 2431
2026
Q1
$75.1K Buy
+1,000
New +$78.9K ﹤0.01% 2413
2025
Q4
– Sell
-20,700
Closed -$1.35M – 3080
2025
Q3
$1.35M Buy
+20,700
New +$1.01M ﹤0.01% 1708
2025
Q1
– Sell
-100,000
Closed -$3.5M – 3276
2024
Q4
$3.5M Buy
+100,000
New +$3.74M 0.01% 1096

Other funds holding IONS

PEAK6's IONS Position: Q3 2026 in Review

PEAK6 reduced its Ionis Pharmaceuticals (IONS) stake by 88% in Q3 2026, selling an estimated $1.47M and leaving 3,678 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #2181.

PEAK6 first reported a position in IONS in Q3 2025 and has held it in 5 quarters since. The position peaked at $2.58M in Q1 2026. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • PEAK6 held 3,678 shares of Ionis Pharmaceuticals worth $164K as of Q3 2026.
  • PEAK6 sold 25,782 Ionis Pharmaceuticals shares in Q3 2026, an estimated $1.47M.
  • Ionis Pharmaceuticals made up ﹤0.01% of PEAK6's portfolio in Q3 2026, its #2181 holding.
  • PEAK6 first reported a position in Ionis Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • PEAK6's Ionis Pharmaceuticals position peaked at $2.58M in Q1 2026.
  • 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on PEAK6's 13F filing for Q3 2026, filed 13 Nov 2026.